In Jul. 2004, it was approved by the European Union to treat some epileptic seizures in adults. In Dec. 2004, it was approved by the U.S. Food and Drug Administration (FDA) to treat diabetic peripheral neuralgia and postherpetic neuralgia. In 2006, generalized anxiety disorder and social anxiety disorder became new indications of Pregabalin. In 2007, Pregabalin was approved by the FDA as the first drug to treat fibromyalgia syndrome. In 2012, Pregabalin was approved by the FDA to treat spinal cord injury (SCI)-related pains. In 2010, Lyrica was approved to enter China.
According to the publisher, the sales value of Lyrica increased by more than 450 times from about CNY 200,000 in 2010 to over 90.74 million in 2018.
Due to Lyrica's success, many domestic manufacturers applied for Pregabalin production. Chongqing Succeway Pharmaceutical Co., Ltd.'s Pregabalin (trade name: Lairuike) was put in the market after obtaining the production license in 2013 and is gradually taking market share from Pfizer.
By sales value, in 2018, Pfizer's Lyrica had a market share of approximately 77.13%, and the rest market share was captured by the products of Chongqing Succeway Pharmaceutical Co., Ltd. It is estimated that Pfizer's Lyrica will continue to dominate the Chinese market from 2020 to 2024 but its market share will decline because of the price competition of China-made Pregabalin.
According to the publisher,there is a continuous rise in the number of people suffering from indications for Pregabalin. For example, the number of epileptics in China has exceeded 10 million and increases by 500 thousand every year. Therefore, Pregabalin has a bright prospect in China.
- Development environment of Chinese Pregabalin market
- Governmental approval of Pregabalin in China
- Prices of Pregabalin in China
- Major Pregabalin manufacturers in China
- Factors influencing the development of Chinese Pregabalin market
- Prospects of Chinese Pregabalin market
1.2 Development Process of Pregabalin in China
1.3 Governmental Approval of Pregabalin in China
1.4 Sales Value over the World
2 Market Overview of Pregabalin in China, 2013-2018
2.1 Investigation on Sales Value of Pregabalin in China
2.1.1 Total Sales Value
2.1.2 Sales Value by Region
2.2 Investigation on Sales Volume of Pregabalin in China
2.2.1 Total Sales Volume
2.2.2 Sales Volume by Region
2.3 Investigation on Market Size of Pregabalin by Dosage Form in China, 2013-2018
3 Investigation on Market Share of Major Pregabalin Manufacturers in China, 2013-2018
3.1 Major Manufacturers of Pregabalin
3.1.1 Investigation on Market Share by sale value
3.1.2 Investigation on Market Share by sale volume
3.2.1 Enterprise Profile
3.2.2 Sales Value and Volume of Pregabalin Produced by Pfizer in China
3.3 Chongqing Succeway Pharmaceutical Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales Value and Volume of Pregabalin Produced by Pfizer in China
4 Sales Price of Pregabalin in China Market, 2019
4.1 Referential Price of Pregabalin in China Hospital Market
4.1.1 Average Price in China
4.1.2 Sales Price of Pregabalin by Region
4.2 Referential Price of Pregabalin in China by Manufacturers
4.2.1 Pfizer (Lyrica)
4.2.2 Chongqing Succeway Pharmaceutical Co., Ltd.(Lairuike)
5 Prospect of Pregabalin Market, 2020-2024
5.1 Factors influencing Pregabalin Market
5.1.1 Driving Forces and Market Opportunities
5.1.2 Threats and Challenges
5.2 Generic Drugs
5.3 Forecast on Market Size of Pregabalin in China, 2020-2024
5.4 Forecast on Competition Pattern of Pregabalin in China
List of Charts
Chart Important Events in Development Process of Pregabalin
Chart Governmental Approval of Pregabalin in China
Chart Patent Information About Pregabalin Registration
Chart Sales Value of Pregabalin over the World
Chart Sales Value of Pregabalin in China, 2013-2018
Chart Sales Value of Pregabalin in Different Regions of China, 2018
Chart Sales Volume of Pregabalin in China, 2013-2018
Chart Sales Volume of Pregabalin in Different Regions of China, 2018
Chart Dosage form of Pregabalin in China
Chart Market Share of Pregabalin in China by sale value, 2013-2018
Chart Market Share of Pregabalin in China by sale volume, 2013-2018
Chart Enterprise Profile of Pfizer Inc.
Chart Sales Value and Volume of Pregabalin Produced by Pfizer in China, 2013-2018
Chart 3.5 Enterprise Profile of Chongqing Succeway Pharmaceutical Co., Ltd.
Chart Average Price of Pregabalin in China Market, 2013-2018
Chart Sales Price of Pregabalin by Region in China, 2017
Chart Referential Prices of Pregabalin Produced by Pfizer GmbH Arneimittelwerk (GE) in China, 2019
Chart Referential Prices of Pregabalin Produced by Chongqing Succeway Pharmaceutical Co., Ltd. in China, 2019
Chart Pregabalin Products Under NMPA’s Approval by the End of 2019
Chart Forecast on Sales Value of Pregabalin in China, 2020-2024
Chart Forecast on Sales Volume of Pregabalin in China, 2020-202
Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.
Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.
Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.
The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.
The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.
1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.